ORIC-944 TFA
ORIC-944 TFA is a potent, orally bioavailable inhibitor of the PRC2 complex. It demonstrates antitumor activity in preclinical models of metastatic prostate cancer, supporting its use in both in vitro and in vivo research studies targeting epigenetic dysregulation.
Product Specifications
Field of Research
Epigenetics & Chromatin, Immunology & Inflammation
Smiles
FC1=CC=C (OCC2) C2=C1CNC3=NC=C (C4=CC=C (CN (C) C) C=C4C) C5=NC (C#N) =CN53.OC (C (F) (F) F) =O
Molecular Formula
C28H26F4N6O3
Molecular Weight
570.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-62755R-BF350 100 µL
NUP155 Recombinant Antibody, AbBy Fluor™ 350 Conjugated
Sign In for Pricing
View Details 
TRV-0035328-01 20 µL
Monoclonal Antibody to Protein Kinase C Beta 1 (PKCb1)
Sign In for Pricing
View Details TRV-0035328-02 100 µL
Monoclonal Antibody to Protein Kinase C Beta 1 (PKCb1)
Sign In for Pricing
View Details TRV-0035328-03 200 µL
Monoclonal Antibody to Protein Kinase C Beta 1 (PKCb1)
Sign In for Pricing
View Details TRV-0035328-04 1 mL
Monoclonal Antibody to Protein Kinase C Beta 1 (PKCb1)
Sign In for Pricing
View Details